Completed Genetics & Molecular Biology Cancer

Genetic instability and death in cancer cells

In plain English

AI plain-English summary

Every time a cancer cell divides, it must copy its entire genome—and that process frequently goes wrong, creating breaks and tangles in the DNA that can either kill the cell or make it more dangerous. This project tackles a fundamental gap in knowledge: how cells respond to stress during DNA replication, and why those responses often fail in cancer. While scientists know that DNA damage triggers repair or cell death, the specific mechanisms at the replication fork—the molecular machinery that unwinds and copies DNA—remain poorly understood. Tumour cells routinely alter these pathways, which helps them survive and resist treatment. If this research succeeds, it could reveal new ways to push cancer cells into self-destruction by exploiting their own replication errors. That might lead to more effective chemotherapy or radiotherapy, or to drugs that selectively kill tumour cells while sparing healthy tissue. The work is fundamental science—it does not promise an immediate treatment. But similar studies of DNA repair pathways have already produced drugs such as PARP inhibitors, which now treat inherited breast and ovarian cancers. A deeper understanding of replication fork stress could open a comparable route for other cancers.

View original technical description
Cells respond to DNA damage by triggering cell cycle arrest, DNA repair or death. There is ample evidence that these pathways play critical roles in tumour development and therapeutic response. The pathways are frequently altered in tumour cells, inherited mutations of several DNA damage response genes predispose to cancer, and the pathways are major determinants of tumour cell response to widely used therapeutic agents. The aims of the four interactive projects proposed here are to understand the role cellular responses to DNA replication fork stress play in the maintenance of genome stability and cellular commitment to death, how these mechanisms become altered in cancer, and how they can be exploited to improve therapy.

View the original record at the funder ↗

Researchers

Mark Meuth (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Cellular responses to DNA damage
DNA damage response mechanisms
Chromosomal Instability in Cancer Pathogenesis and Treatment (MRC Programme 1)
Molecular basis of inheritable DNA lesions on genome transformation.
Targeting DNA Replication in Cancer: Towards New Therapeutics with Reduced Side Effects

Original classification

Research

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.